Trending Now
Applied DNA Sciences Inc. (NASDAQ: APDN): Expanding Horizons in DNA Technology...
Applied DNA Sciences Inc. (NASDAQ: APDN), a leader in PCR-based DNA technologies, has once again made headlines with a significant development in...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Xenon Pharmaceuticals (XENE) could rally based on XEN1101
Xenon Pharmaceuticals (XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological...
MAKE IT MODERN
LATEST REVIEWS
BeiGene (BGNE): The Biotech Gem Investors Need to Watch Closely
Investors in the biotech space have a potential goldmine on their radar: BeiGene (BGNE). Jefferies, a global financial services company, recently weighed...
MAKE IT MODERN
PERFORMANCE TRAINING
PTC Therapeutics, Inc. (NASDAQ: PTCT) Announce That Brazil’s Drug Market Regulation Chamber Has Granted...
PTC Therapeutics, Inc. (NASDAQ: PTCT) has announced that Waylivra has obtained Category 1 classification from the Câmara de Regulaço do Mercado de Medicamentos -...
Etsy Inc (NASDAQ:ETSY) presents a buying opportunity and here’s why
Etsy Inc (NASDAQ:ETSY) is currently trading at $107.2, up a minuscule 0.18% today. More than 1M shares have exchanged hands compared to...
Xeris Pharmaceuticals Inc (NASDAQ:XERS) Announces its Corporate Highlights and Pipeline Breakthroughs for Q2 of...
Xeris Pharmaceuticals Inc (NASDAQ:XERS) has been working on developing ready-to-use (RTU) solutions for various therapeutic areas. The company has had breakthroughs in areas such...
Humanigen Inc. (NASDAQ: HGEN) Announces Strategic Realignment To Expedite Lenzilumab Development For CMML Treatment
Humanigen Inc. (NASDAQ: HGEN) has announced the strategic realignment of its resources and pipeline in a bid to achieve its main clinical milestone. The...
TG Therapeutics Inc. (NASDAQ: TGTX) Announces A Schedule For Data Presentations Of ULTIMATE I...
TG Therapeutics Inc. (NASDAQ: TGTX) has announced the timetable of data presentations showing data from ULTIMATE I & II third phase studies evaluating ublituximab...
MAKE IT MODERN
